Author

Bindia Jharap

CONTINUATION OF ANTI-TNF IN PATIENTS WITH ULCERATIVE COLITIS IN REMISSION IS NOT COST-EFFECTIVE COMPARED TO TREATMENT WITHDRAWAL: A MARKOV MODEL
CONTINUATION OF ANTI-TNF IN PATIENTS WITH ULCERATIVE COLITIS IN REMISSION IS NOT COST-EFFECTIVE COMPARED TO TREATMENT WITHDRAWAL: A MARKOV MODEL

Bindia Jharap  et al.

PREVALENCE OF IRON DEFICIENCY AND ANAEMIA IN THE OUTPATIENT INFLAMMATORY BOWEL DISEASE POPULATION: A DUTCH NATIONAL CROSS-SECTIONAL STUDY
PREVALENCE OF IRON DEFICIENCY AND ANAEMIA IN THE OUTPATIENT INFLAMMATORY BOWEL DISEASE POPULATION: A DUTCH NATIONAL CROSS-SECTIONAL STUDY

Bindia Jharap  et al.

SUPERIOR EFFECTIVENESS OF TOFACITINIB COMPARED TO VEDOLIZUMAB IN ANTI-TNF EXPERIENCED ULCERATIVE COLITIS PATIENTS: A NATIONWIDE DUTCH REGISTRY STUDY
SUPERIOR EFFECTIVENESS OF TOFACITINIB COMPARED TO VEDOLIZUMAB IN ANTI-TNF EXPERIENCED ULCERATIVE COLITIS PATIENTS: A NATIONWIDE DUTCH REGISTRY STUDY

Bindia Jharap  et al.

WITHDRAWAL OF THIOPURINES IN INFLAMMATORY BOWEL DISEASE PATIENTS IN STABLE REMISSION: A PROSPECTIVE, MULTICENTER COHORT STUDY
WITHDRAWAL OF THIOPURINES IN INFLAMMATORY BOWEL DISEASE PATIENTS IN STABLE REMISSION: A PROSPECTIVE, MULTICENTER COHORT STUDY

Bindia Jharap  et al.

Item 1 - 4 / 4
1